Try GOLD - Free
New labelling rules to help patients select pills wisely
Mint Mumbai
|July 03, 2025
Ever squinted at a medicine strip trying to find the expiry date, or popped a pill without knowing whether it's branded or generic? You're not alone.
India's top drug regulator is stepping in to change that. The Drug Controller General of India (DCGI) is working on a nationwide overhaul of medicine packaging and labelling norms.
The goal is to make expiry dates and batch numbers easier to read, reduce confusion between generic and branded drugs, and help patients make better-informed choices, two government officials aware of the matter said.
As part of the proposed changes, manufacturers may soon be required to use larger fonts, ditch shiny packaging that reflects light and obscures print, and print expiry dates in more than one place to prevent vital information from being torn off.
There's also a plan to introduce a universal symbol to clearly distinguish generic medicines from branded ones.
The regulator had received several complaints regarding the difficulty in differentiating between cheaper generic drugs and their branded counterparts, and consequently, the pricing comparison.
"The drug regulator has received various complaints and demands from the consumers regarding the labelling of medicinal products such as tiny font size of the letters printed on the drug packaging, shiny labels, the expiry date of the medicines getting torn while taking out the medicine, and demand for a universally recognized symbol on the generic medicines that will distinguish it from the branded medicines," said one of the officials cited above, requesting anonymity.
This story is from the July 03, 2025 edition of Mint Mumbai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Mumbai
Mint Mumbai
Infosys may lose $150 mn a year from Daimler
Infosys Ltd risks losing over a third of its $400 annual revenue from Daimler, one of its three largest clients, as the German auto giant seeks a new vendor for software and equipment following execution delays, according to two people familiar with the details.
3 mins
January 12, 2026
Mint Mumbai
Market braces for turbulence as FPI shorts hit record
Indian markets could turn choppier early this week with foreign portfolio investors (FPIs) raising bearish index futures bets to a record high on Friday, ahead of the US Supreme Court decision this week on the validity of president Donald Trump's tariffs.
2 mins
January 12, 2026
Mint Mumbai
The extraordinary video grab has had a very short life
It would appear that we are still in the era of extraordinary mobile-phone videos.
4 mins
January 12, 2026
Mint Mumbai
Clean slate in IBC to be reality soon
Govt accepts panel suggestions, no retrospective application
2 mins
January 12, 2026
Mint Mumbai
Why waiting for a crash can cost you more than investing at highs
Data over the decades shows timing matters far less than staying invested, whether through SIPs or lump sums
4 mins
January 12, 2026
Mint Mumbai
The long tail of a blockbuster—Collections beyond the box-office
The box-office is no longer the only engine of value for a successful film.
3 mins
January 12, 2026
Mint Mumbai
Swiggy scales up Noice to expand private-label play
Swiggy’s Noice expanded its supplier base from 40 to nearly 70 contract manufacturers
2 mins
January 12, 2026
Mint Mumbai
Elon Musk relies on Gwynne Shotwell to make SpaceX soar
Gwynne Shotwell, the longtime president of SpaceX, confronted a delicate problem last June.
6 mins
January 12, 2026
Mint Mumbai
NSE’s unlisted shares in focus as IPO fog clears
The unlisted market could be in for a flurry of activity, with the National Stock Exchange (NSE) likely to get the market regulator’s approval to begin its listing process by the end of this month.
2 mins
January 12, 2026
Mint Mumbai
Hedge funds get ready for the 'Donroe Doctrine' trade
Call it the “Donroe trade.”
4 mins
January 12, 2026
Listen
Translate
Change font size
